REGENXBIO (NASDAQ:RGNX) Upgraded at Royal Bank of Canada
Royal Bank of Canada upgraded shares of REGENXBIO (NASDAQ:RGNX – Free Report) from a sector perform rating to an outperform rating in a research note released on Friday morning, Marketbeat Ratings reports. Royal Bank of Canada currently has $35.00 price objective on the biotechnology company’s stock, up from their prior price objective of $20.00. Several […]
More Stories
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...
GGL Resources (CVE:GGL) Stock Price Up 33.3% – Should You Buy?
GGL Resources Corp. (CVE:GGL – Get Free Report)’s share price rose 33.3% during mid-day trading on Saturday . The stock...
Chanson International (NASDAQ:CHSN) versus Nestlé (OTCMKTS:NSRGY) Critical Survey
Nestlé (OTCMKTS:NSRGY – Get Free Report) and Chanson International (NASDAQ:CHSN – Get Free Report) are both consumer staples companies, but...
Arctic Star Exploration (CVE:ADD) Trading Up 50% – Still a Buy?
Shares of Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shot up 50% during mid-day trading on Saturday ....
Head to Head Comparison: iTeos Therapeutics (NASDAQ:ITOS) & Invivyd (NASDAQ:IVVD)
Invivyd (NASDAQ:IVVD – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but...
Oracle Power (LON:ORCP) Trading Down 14.3% – Here’s Why
Oracle Power plc (LON:ORCP – Get Free Report)’s share price traded down 14.3% during mid-day trading on Saturday . The...